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Abstract
Purpose – The establishment of partnerships between companies, government and universities aims to
enhance innovation and the technological development of institutions. The biotechnology sector has grown in
recent years mainly driven by its cooperative business model. Compared to other countries, this sector is
slowly advancing in Brazil, with delays in science, technology and innovation, especially in the private sector.
This paper aims to examine, through social network analysis, the collaborative networks between institutions
that ﬁled patents in biotechnology –medicinal preparations from plants – whose inventions had Brazil as the
priority country.
Design/methodology/approach – The study of technological cooperation using patent documents
is a reliable approach as they serve as good indicators of the interactions between organizations
that focus on innovation and development of new product. Social network analysis of
cooperation networks helps to understand the connections between patent assignees, and how they establish
relationships.
Findings – Results show that public universities are the institutions that most deposit patents, as well as
those that co-operate the most, especially Universidade of Campinas. The study also reveals the critical
role of Research Support Agencies in stimulating research and technological development, which result in
new technologies.
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Originality/value – The study applied the social network analysis to provide an overview of the
interactions among Brazilian institutions with the purpose of helping in decision-making and inciting public
policies to leverage the biotechnology sector.
Keyword Social network analysis
Paper type Research paper
1. Introduction
According to the Organization for Economic Cooperation and Development (OECD, 2008),
innovative potential depends on how knowledge progresses and on the structure of
connections of each country’s National Innovation System (NIS). In this regard, the
importance of establishing partnerships between companies, government and universities,
aiming to enhance technological innovation, has been discussed and emphasized over the
years in studies that address NIS (Freeman, 1995; Nelson and Rosenberg, 1993; Lundvall,
1992), open innovation (OI; Chesbrough, 2003) and, more recently, the joint-product
orientation (Foray and Lissoni, 2010).
In an NIS, the innovative process occurs through the ﬂow of technology and information
between the actors of this system, who can be individuals, companies, universities,
governments and research institutes, among others. Regarding the same issue, the triple
helix innovation model is based on the relationship between government, industry and
university. The latter is the driver of connections with the production sector of goods and
services, represented by industry and with the government, which regulates economic
activity (Leydesdorff and Etzkowitz, 1996). On the other hand, OI stresses the ability of
organizations to effectively articulate the use of their internal and external resources, such
as ideas, skills, projects, infrastructure, technologies and capital (Rogbeer et al., 2014).
Therefore, this model requires organizations to open their borders to enable innovations
from internal and external combinations of resources, in view of two main objectives: to
absorb external assets and to allow the licensing of the internal means that the ﬁrm will not
use, avoiding the loss of investments alreadymade (Chesbrough, 2003).
Yet, Foray and Lissoni (2010) present a proposal for the management of research,
development and innovation (R&D&I), where they replace the vertical structure (by-product
orientation), by a shared vocation, the joint-product. This view considers that products with
shared technology achieve better results in terms of sales, in addition to lower R&D costs and
risks. The development process must be shared with the most competent actors since the
beginning, by involving companies and universities to shape strategic relationship networks.
The determinants of a stronger cooperation between institutions, as well as their
beneﬁcial effects for innovation, are well established in the literature. However, more studies
are necessary to improve the visualization and interpretation of these relationships, allowing
the identiﬁcation of the main actors and those more prone to establish partnerships, as well
as the dynamics of collaboration between institutions over time. The innovation process is
complex, and the way actors interact with each other can deﬁne the result of the cooperative
effort. As interactions between institutions to achieve innovative results shape a network
structure, a valuable tool for understanding and better viewing cooperation between ﬁrms,
government and universities is to use the metrics and concepts of social network analysis
(SNA).
This study, in addition to presenting SNA’s methodological features to measure
cooperation between institutions, examines a sample of cooperative projects on medical
preparations that contain products of plant origin, which resulted in joint technological
development with patent applications, where Brazil is the ﬁrst country of deposit. The basis
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of the study is the success of the new business model, ﬂexible and open to partnerships,
which the biotechnology sector has taken advantage of in the recent years. It focuses on a
speciﬁc segment related to herbal products with medical and cosmetic application that were
ﬁrst protected in Brazil. This is a relevant topic as the variety of Brazilian biomes reﬂects the
enormous richness of the country’s ﬂora and fauna, which houses the largest biodiversity
in the planet. The country owns about 20 per cent of the world’s biodiversity, and the
largest regarding plants, with more than 50,000 listed species of trees and bushes. Higher
plants, although better indexed, are still far from a reliable total count, and there are
estimates that 10 per cent of the Brazilian species have not yet been cataloged (Lewinsohn
et al., 2001).
This paper presents an analysis of the global scenario of these patents with the evolution
of ﬁlings over the last 20 years, the main inventors and the kinds of actors – companies,
universities and research institutes. It also shows the proﬁle of the partnerships between
institutions and highlights the main patent holders with technological capability to generate
inventions that adopt the collaborative R&D business model.
Following the introduction, the structure of the article consists of a theoretical
background on the positive aspects of establishing cooperation, and the importance of
adopting SNA for its study. In sequence, we present the methodological approach used in
the study, the results and discussion and at the end, the conclusions and future perspectives.
2. Literature review
2.1 Technological cooperation networks to foster innovation
Collaborative R&D efforts for new technologies are common in several companies and
sectors, and their relevance to the innovation and technological development has been
highlighted under different views. Crespo et al. (2015) argue that the knowledge built over
the years through R&Dmanagement studies proves the importance of collaborations, which
lead to higher capacity for innovation and growth. Geum et al. (2013) observe that the
beneﬁts of collaborative efforts are evident and stem from the use of external knowledge,
which results in diversiﬁcation of technological skills and increases the pace of production
of new technologies. In a recent study, Su (2017) drew on the phenomenon of economic
globalization to investigate the interdependency between R&D global partners, pointing to
the relevance of international partnerships, which would increase the creation and ﬂow of
knowledge, along with the expansion of potential applications of the developed technologies.
Mitze et al. (2015) conducted a survey in Germany to measure R&D performance in small
and medium companies; they concluded that the most important R&D performance
indicators are higher in organizations that make collaborative efforts, in comparison to those
that do not conduct them. Spanos et al. (2015) also used surveys to investigate the impact of
R&D partnerships funded by governments on the innovation of products and processes, as
well as on the inimitability of technologies; they concluded that companies that cooperate
show a better performance. Masum et al. (2013) suggest ten rules that should be applied for
the effective execution of collaborative R&D and open innovation, suggesting that such
efforts can help minimize the two main problems of technological development: the
complexity and high costs of applying scientiﬁc developments to produce changes and
social advances. According to the literature review, globalization is one of the big reasons
collaborations have become more important and attractive, especially since the culture of
foreign direct investment intensiﬁed, as of the 1990s (Su, 2017).
Regardless of the advantages that literature associates with collaborations, one of the
major challenges is the correct identiﬁcation and selection of partners (Geum et al., 2013),
and there is evidence that partnerships between private companies and universities have the
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highest potential to achieve good results (Mitze et al., 2015). As for the information used in
studies of collaborative networks, bibliographic data (Geum et al., 2013) and patent data
(Crespo et al., 2015; Mitze et al., 2015; Su, 2017) prevail.
Although still not as plentiful as abroad, Brazilian studies on collaborative networks and
on cooperation in R&D activities are growing in national literature. Alonso-Arroyo et al.
(2016) conducted a survey to analyze research collaborations between Brazilian and Spanish
institutions in the medical sector, through bibliometric analysis. They concluded that the
amount spent on collaborative research as well as the number of collaborations have
increased signiﬁcantly in Brazil, either through partnerships with European and Latin
American countries or with the USA. Another study used SNA to investigate scientiﬁc
cooperation in nanotechnology in the agricultural sector, and observed a strong integration
between Brazilian researchers in this area (Campos et al., 2017).
A study leaded by de Sousa et al. (2015) observed that R&D collaborations improve the
ﬂow of knowledge which positively inﬂuence the performance of Brazilian industrial ﬁrms
as well as the rate of success in product innovation. They further expanded the analysis and
concluded that collaborative efforts between private companies and public sector
organizations bring economic beneﬁts by stimulating the country’s growth and improving
the performance of the national innovation system. Gomes Costa et al. (2018) examined the
curricula of researchers, between 1980 and 2010, to investigate scientiﬁc collaborations in
biotechnology in Northeastern Brazil. They observed the formation of some collaboration
clusters (based on geographic proximity and laboratory infrastructure), although with a
stronger emphasis on intra-institutional partnerships.
The literature on R&D collaborative networks in biotechnology shows that all the
advantages of cooperation mentioned before apply to this sector. In addition, owing to their
own features, collaborations for scientiﬁc and technological development in this ﬁeld have
an even more relevant role as they focus on knowledge and innovation; therefore, companies
that make alliances for technological development are more likely to get patents (Al-Laham
et al., 2011).
Regarding intellectual property policies, Stevens et al. (2016) noticed that there is a strong
trend in the biotechnology sector to use public–private partnerships (PPPs) to develop better
therapies. Chen and Lin (2016) concluded that biotechnology companies should maintain
partnerships with universities to increase their innovation capabilities and improve the
marketing of new products. After examining potential trading strategies for biotechnology
products, Fernald et al. (2015) mention three types of collaborations used in this sector:
(1) informal interactions and knowledge transfer within clusters;
(2) intellectual property licensing and collaboration agreements; and
(3) acquisition of small companies that hold intellectual property.
Other studies restate the advantages of collaborative efforts for this sector. Such
collaborations would be advantageous for companies by bringing faster advances to
technological development (Eslami et al., 2013), by providing start-up companies with the
necessary expertise to market their products (Fernald et al., 2015) and by facilitating the
transfer and absorption of skills that result in innovations and new products (Al-Laham et al.,
2011).
Collaborations are important for biotechnology owing to the multidisciplinary proﬁle of
this sector: they involve multiple institutions of different kinds (Powell et al., 1999); they
facilitate the ﬂow of information between the participating organizations (Hazir and Autant-
Bernard, 2014); and they allow access to external knowledge, which is an efﬁcient way to
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achieve strategic competitiveness (Al-Laham et al., 2011). In addition, collaborations in
biotechnology result in better products, more innovation and lower risk of development
(Kamuriwo and Baden-Fuller, 2016) and the increase in knowledge ﬂow from cooperation
efforts may be an advantage for companies of this and other high-tech sectors (D’Amore
et al., 2013).
2.2 Social networks analysis related to cooperation studies
SNA is considered an appropriate method to view the relationships between network
participants, and has gained relevance in scientiﬁc articles (Su, 2017), with applications in
several cases (Chen and Lin, 2016; D’Amore et al., 2013; Schiffauerova and Beaudry, 2012). In
SNA, the network is a non-linear, decentralized, ﬂexible, dynamic structure, with undeﬁned
boundaries, self-organizing, established through horizontal relations of cooperation
(Borgatti and Halgin, 2011; Tomaél et al., 2006). Nodes, also called actors, spots or vertices,
are the discrete units that connect to each other through their intrinsic attributes, previously
deﬁned by the researcher. Their study stems from the analysis of the relationship between
these nodes, also called a link or arch. Such relationships can be divided into directed, where
actors either transmit or receive connections, and nondirected, where they carry out the two
functions simultaneously.
Among the studies that investigated the results of R&D&I through network analysis,
two main areas of application stand out. One aimed at understanding how networks can
affect economic activity, such as R&D and patenting in an industry; and the other focused
on the ability to reveal the process of networks formation and their inﬂuence on a particular
topic. Cantner and Graf (2006) applied SNA to describe the evolution of the innovation
network in Germany between 1995 and 2001; Owen et al. (2012) focused on R&D cooperation
by comparing the organization of scientiﬁc research in the USA and Europe through
network analysis.
A second set of papers shows the use of SNA to study the relationship between common
academic inventors in patenting processes, with a focus on different technological categories
(Balconi, et al., 2004). Paci and Batteta (2003) investigated localized transfer of knowledge
and examined technological networks represented by patent citation ﬂows in different
sectors. Studies on collaboration networks seek to explain the performance of individual
actors by using the attributes of the network where they take part, by describing the
structures of the collaboration network or even justifying the network’s development and
dynamics (Van Der Valk and Gijsbers, 2010).
Bazzo (2010) analyzed technological cooperation that resulted in patents in Brazil and
found that subsidiaries of foreign ﬁrms, universities and research institutes exhibit a low
sharing of patent ownership; that is, they do little cooperation, which is an indication of the
institutional fragility of local innovation. The number of publications and patents in
common is a very important indicator for measuring innovation activities and knowledge
interaction between actors (Inzelt, 2004). A recent study, also using patent data, carried out a
dynamic comparative analysis of interorganizational innovation networks of Brazilian and
Spanish biotechnology companies, and used SNA to design and measure network attributes
(Gomes et al., 2017) . Results showed an impressive growth of innovation networks in the
two countries, but Brazil had a lower rank in terms of frequency, volume of partnerships,
diversity of partners and the main types of actors.
Patent data are one of the key indicators used by researchers to evaluate R&D&I results
(Jaffe and Trajtenberg, 2002; Trajtenberg, 1990). Although they are not perfect indicators
(Dosi, 1982), they are a signiﬁcant factor of income generation from technologies, especially
in industries that require large R&D investments, such as the chemical–pharmaceutical,
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responsible for launching active agents and formulations, and the biotechnology. Patent
analysis provides key information to executives in charge of research and development,
technological policies or technological strategy in a company (von Wartburg, Teichert and
Rost, 2005; Yoon and Park, 2004), especially in the biotechnology sector.
Along with information technology, this is the fastest growing industry in the twenty-
ﬁrst century (Gartland et al., 2013). Global market was estimated at US$369.62 billion in
2016 and is expected to reach US$727.1 billion in 2025, mainly owing to the establishment of
partnerships (Grand View Research, 2017). The largest segment of the biotechnology
market is healthcare and medical applications, accounting for 66.2 per cent of the total
market value (Soh and Subramanian, 2014). With the increasing importance of this sector
and large R&D investments and efforts worldwide, it becomes critical to ensure appropriate
protection for the new and revolutionary technologies (Gupta and Subbaram, 1992; Karki
and Garg, 1993).
3. Methodology
The study is an exploratory–descriptive research of qualitative and quantitative nature,
regarded the analysis of patent databases in biotechnology, especially the use of plants (and
their derivatives) for the formulation of drugs and cosmetics. As an indicator of
technological production, we used the patentometrics technique, associated with the
analysis of co-ownership of patents ﬁled primarily in Brazil. With this study, we expect to
present an overview of the patent scenario in a segment of biotechnology, as well as to
understand how institutions established partnerships that resulted in patent ﬁlings. Next,
we present the topic of the research; how we accessed, collected and analyzed the patent
database; and ﬁnally, how we used the SNA approach to study cooperation between
institutions.
In the last decades, great expectations emerged regarding potential developments in
biotechnology. Brazil has been following this process and has systematically implemented
policies for its evolution. Among the most relevant aspects of these policies are the support
of new companies and the growth of the business sector devoted to biotechnology (Bianchi,
2013). The mastery and use of modern biotechnology require access to advanced
technologies that are already available in developed countries; in Brazil, these are located in
regions where academic, technological and business development are strongly concentrated,
such as Southeast and South regions (Gomes Costa et al., 2018). Thus, this shows the critical
importance of establishing partnerships.
The rich Brazilian biodiversity is one of the most important global sources for the
development of phytocosmetics and drugs that contain active principles of plant origin. The
cosmetics sector beneﬁts from it and has gained prominence in recent years. Cosmetic
preparations with natural raw materials grow at considerable annual rates in the
international market, between 8 and 25 per cent above the observed growth rates among
products formulated with synthetic ingredients. Owing to the wide diversity of chemical
derivatives from plant extracts, which have different actions, a major effort is taking place
to generate investments in research and development for the discovery of new drugs
containing natural ingredients. About 30 per cent of the available drugs derive directly or
indirectly from natural products, mostly from plants. In diseases like cancer, the use of
drugs derived from plants is even higher, reaching 60 per cent (Boldi, 2004; Newman et al.,
2002).
Although Brazil has a huge biodiversity, it has not been able to develop a signiﬁcant
amount of innovative products. The local industry of herbal drugs holds a technical capacity
and is willing to invest in new products; however, it has faced practical difﬁculties that
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obstruct and sometimes render impossible the realization of its projects (ABIFINA, 2011).
Hence, it is extremely important that the country keeps investing in the sector, and to do
this, it is necessary to join experiences and share knowledge through institutional
partnerships.
3.1 Patent database
We selected the technological area by using the International Patent Classiﬁcation (IPC)
code A61K 36/00, which addresses “Medical preparations of indeterminate constitution
containing material from algae, lichens, fungi or plants, or their derivatives”. These include
all subgroups, except codes A61K 36/02 to A61K 36/09, which deal with drugs that contain
materials derived from algae, fungi and lichens (WIPO, 2017). We extracted the patent
database from Derwent Innovation database, of Clarivate Analytics, by searching patents
using the ﬁeld “IPC Current”, for all IPCs previously described, along with the ﬁeld
“Publication year”, between 1995 and 2014.
Next, we used the subﬁlter for adding the country “Brazil” to the ﬁeld “Priority Country”.
Altogether, we examined 191 IPCs’ classes and subclasses, totaling 225,327 International
Patent Documentation (INPADOCs), of which 466 were object of the research. We selected
all INPADOCs’ families resulting from the search and exported them in a Microsoft Excel
ﬁle, to create the patent database. Due to the 18-month conﬁdentiality period, we decided not
to include the years 2015 and 2016 as most of the patents of this period have incomplete
information.
3.2 Document analysis and data preparation
Information on patent number, country code for technology protection, inventors, holders
(assignees), date of publication and ﬁling of patents and technology areas (IPCs) were
collected for further comprehensive analysis of the documents and graphic design. We
standardized the names of all patent holders using theOpenReﬁne freeware tool (openreﬁne.
org), to generate the collaboration networks.
3.3 Social network analysis
We carried out the building and analysis of cooperation networks according to the method
and protocol described by Pereira and Porto (2018) and Pereira et al. (2018) and their
adaptations. Brieﬂy, information of assignees and code of all patents, represented by
INPADOCs, were grouped in an Excel spreadsheet. The presence of co-owners in the
“Assignee” ﬁeld indicates partnership relationships, and as peers share more patents
between them, higher is the weight given to the link between holders. We uploaded data on
patent code and owners to freeware Gephi (www.gephi.org). To analyze data, we created a
bipartite network, containing a spreadsheet of nodes (patents and holders) and a
spreadsheet of edges (patents related to their owners). In the global network, nodes’ sizes
were adjusted according to their degree, and the color according to their category (patents in
blue and owners in red). The holders’ network was created by using the plug-in Multimode
Networks Transformation (https://github.com/jaroslav-kuchar/Multimode-Networks), which
eliminated patent nodes and turned them into a criterion of link between holders. Standard
statistical measures available in Gephi were used, such as modularity (Blondel et al., 2008),
average degree, weighted average degree and centrality. The network of the largest holders
was extracted from the global network through the “ego network” ﬁlter, following the node’s
ID command.
INMR
15,4
422
D
ow
nl
oa
de
d 
by
 1
89
.4
4.
84
.1
06
 A
t 1
2:
18
 0
4 
D
ec
em
be
r 2
01
8 
(P
T)
4. Results and discussion
The study addressed the analysis of technological collaboration networks that resulted in
patents in biotechnology related to drugs and cosmetics containing products of plant origin
and their derivatives (IPC classes A61K 36/10 to IPC A61K 36/9068), whose invention has
Brazil as the priority country, that is, the ﬁrst country where patents were ﬁled. Altogether,
we found 742 documents, of which 466 INPADOCs (patent families), that is, distinct
inventions that were ﬁrst ﬁled in Brazil. The trend line shows that since 2006, there has been an
exponential growth in the number of patent publications in this topic in Brazil [Figure 1(a)] .
Figure 1.
Evolution of the
publication and
geographic coverage
of patents priority
ﬁled in Brazil in the
period 1995 to 2014 in
the sector of
medicinal
preparations
containing products
of plant origin and
their derivatives
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This considerable increase in the number of patents may reﬂect the National Policy for
Medicinal Plants and Phytotherapics, approved by Decree No. 5,813, of June 22, 2006. This
policy favors the safe access to these plants and their rational use in Brazil, with the
development of technologies and innovations, as well as the strengthening of chains and
productive arrangements, for the sustainable use of Brazilian biodiversity and the growth of
the Healthcare Productive Complex (Ministério da Saúde, 2006).
We also examined the inventions with regard to the coverage of countries where patents
were ﬁled or granted, after the ﬁrst request in Brazil. Results showed that of the 466
INPADOCs, 378 applied for protection only in Brazil, 69 were ﬁled internationally through
Patent Cooperation Treaty (PCT) and 8 were ﬁled in the USA. Requests for protection at the
Canadian and Australian ofﬁces followed, with six and three inventions, respectively
[Figure 1(b)]. It is worth noting that although Brazil has several native plants with
technological potential, shown by patent requests, most of them are still ﬁled only by foreign
companies (Moreira et al., 2006).
Among the technological areas represented by IPCs, which classify inventions, we
highlight the top 10 IPC codes [Figure 2(a)]. The twomost frequent, with 68 documents each,
were A61K 8/97 (cosmetics or similar preparations for personal hygiene characterized by a
composition containing materials or their derivatives of unknown plant origin constitution,
such as plant extracts) and A61K 36/185 (medicinal preparations containing materials of
undetermined constituents derived from dicotyledonous plants). In sequence, with 66
documents, comes IPC A61K 36/28 (medicinal preparations containing materials of
undetermined constituents derived from Asteraceae or compositae plants – family of the
aster or sunﬂower – like chamomile, tansy, Aquileia or Echinacea) and IPC A61K 36/48
(medicinal preparations containing materials of undetermined constituents derived from
Fabaceae or leguminosae plants – pea and legumes) [Figure 2(a)]. Plants of the family
Asteraceae and Fabaceae are the most diverse in number of species found in the country
(Giulietti et al., 2005), which justiﬁes the higher number of patents in these speciﬁc classes.
Among patent holders, we found 51 universities, with 200 documents (with proprietary
technology or in collaboration). On the other hand, we identiﬁed 56 companies as assignees
of 100 patents. These results show that although the number of universities is smaller than
the number of companies, they have twice the potential to generate technologies
(represented by patents) in this sector. Another fact that conﬁrms this ﬁnding is the
Figure 2.
The top ten most
frequent
technological areas
and the top 15 largest
assignees in relation
to the number of
INPADOCs
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presence of public universities among the seven largest patent holders [Figure 2(b)]. On this
issue, Soh and Subramanian (2014) argue that collaborative R&D efforts in biotechnology
are extremely important because universities and research centers are those that develop
more technologies in this area. In Brazil, companies are much dependent on knowledge
generated by universities, which are their main partners (Gomes et al., 2017). The use of
knowledge produced at Science and Technology Institutions (ICTs) represents a rich source
of information and qualiﬁcation for the development of new technologies; once transferred
to the manufacturing sector, they promote an alternative and complementary path for
companies to reach a higher technological level (Garnica and Torkomian, 2009).
In a list of the top 15 patent holder institutions, the ﬁrst is University of Campinas
(UNICAMP) with 20 ﬁlings. Next come the Federal University of Minas (UFMG, Gerais)
and University of São Paulo USP) with 14 patents each, UFPR (Federal University of
Paraná) in the third place with 13 documents, fourth is the Federal University of
Maranhão (UFMA) with 10 and in the ﬁfth place is UEM (State University of Maringá),
with nine documents. Among the 15 largest holders, 10 are universities, two are Research
Support Agencies (FAPs), two are private companies and one is an individual. It is
important to highlight the presence of individuals or inventors as patent holders.
Altogether, we found 353 different individuals, either with proprietary technology or as
co-owners. Buttow and Steindel (2012) analyzed patent ﬁling in subclass C12N (also
related to biotechnology) in Brazil and found that the four largest holders present in our
research were the main requesters in the period 2001-2005, showing that these
institutions are still operationally relevant.
The network, which shows the connections between patent holders and the patents they
share, is called a bipartite network, where two different categories of nodes are displayed
(Figure 3). Blue nodes represent the patents and red nodes the holders. The relationship
between them is established according to the information of co-ownership in the patent
document. The bipartite network has 225 connected components, with a value diameter
equal to 13, and average degree equal to the weighted average degree of 1,627; that is, in this
network, the holder relates to the same patent only once (that is why the edges have a weight
equal to 1). In addition, we identiﬁed the node of higher centrality of the eigenvector type –
UNICAMP –, as the node of greatest inﬂuence in the network, owing to its connections.
The technology collaboration network between the holders emerged from the general
network, through the application of the multimode networks transformations plugin,
available in Gephi (Figure 4). In this case, the network only shows the connections between
the holders (nodes), represented by the patents in partnership and the number of patents
they share, which is an element that affects the weight of the edge (edge thickness) that
connects the nodes. In this case, the collaboration network has 477 nodes (or holders), among
which are companies (56), governmental institutions (17), universities (51) and inventors
registered as holders (353). The technological cooperation network has 222 components,
with a value diameter equal to 6, average degree of 3.11 and a weighted average degree of
3.417, showing that partnership relationships are still scarce. UNICAMP stands out as the
institution with the highest number of connections (45), greater centrality of intermediation
and greater centrality of the eigenvector type, assuming the role of the holder that most
builds partnerships among Brazilian institutions. UNICAMP was previously cited as the
second largest requester of medicinal plants, speciﬁcally the use of andiroba, only behind
Fiocruz (Amaral and Fierro, 2013).
Although UNICAMP is the institution with the largest number of cooperation
agreements, these have resulted, at most, in two patents with the same partner; this means
that cooperation relationships are not persistent and lasting, and the institution is not
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present on the list of cooperative relationships that most resulted in patent ﬁlings (Table I).
In this respect, it is worth emphasizing that there is indeed a gain in strategic
competitiveness by using collaboration, but there is a limit to that gain, and companies must
be careful when establishing partnerships to avoid an excessive number of alliances that
could undermine their innovative capacities, rather than help them (Fernald et al., 2015).
Among the collaborations with greater sharing of patent ownership, we highlight the
Federal University of Viçosa (UFV) with FAPEMIG (Research Support Agency of the State
of Minas Gerais), and USP with FAPESP (Research Support Agency of the State of São
Paulo), and these collaborations yielded ﬁve patents to each institution. This shows the
important role of these state agencies for the incentive and strengthening of research and
technological development in Brazil. There are also signiﬁcant partnerships between
universities of the same state, such as UFVwith Federal University of Ouro Preto (UFOP), in
Minas Gerais, and USPwith UNESP (São Paulo State University), which resulted in four and
three patents, respectively (Table I).
For a better view of the collaboration networks between the institutions, we selected,
from the general network of holders, the ego network with depth 2 (except UNICAMP) for
the owners with the highest number of patents (Figure 5). UNICAMP’s ego network had
Figure 3.
Global bipartite
network of
interactions among
patents and its
assignees. The knots
in blue are patents
and their holders are
in red
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depth 1 as the institution has partnerships with a series of other owners and many of them
are individuals who, in turn, also have subsequent partnerships; in this case the ego network
with depth 2, would be very large, which would hamper the analyses. We highlight that
UNICAMP mainly cooperates with individuals, and these collaborations did not result in
other patents (few edges with weight above 1).
Table I.
Cooperation among
assignees that
produced the most
patents for the sector
of medicines and
cosmetics containing
material of plant
origin and its
derivatives
Assignee 1 Assignee 2 Patents in cooperation
UFV FAPEMIG 5
USP FAPESP 5
UFV UFOP 4
UNICAMP Foglio, Mary Ann 3
USP UNESP 3
Catarinense S.A. Lab Batista Calixto, João; Silva Filho, Osvaldo; Fujii, Tadaﬁssa 3
Figure 4.
Collaboration
network among
patent assignees for
the sector of
medicinal
preparations
containing products
of plant origin and
their derivatives, and
that had inventions
deposited ﬁrst in
Brazil
Brazil as the
priority
country
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Yet, in the case of UEM, we observed that it has collaborations that resulted in more than
one patent, with private institutions such as Bionatus and Apsen Pharmaceutical, indicating
that these partnerships are lasting. In relation to USP’s ego network, we observe a
collaboration hub of this university with FAPESP (ﬁve patents) and UNESP (three patents),
showing a strong connection between them. A recent study that examined patents from the
twelve largest Brazilian universities showed the central role of FAPESP in promoting
innovation, by interacting not only with universities located in the state of São Paulo, but
also with UFMG (Fischer et al., 2018). In our study, FAPESP showed a similar performance,
with cooperative ties with the Federal University of Lavras, located inMinas Gerais.
UFMG’s ego network shows the importance of partnerships between geographically
close universities located in Minas Gerais, and the relevance of FAPEMIG actions to
encourage research that results in innovation. There is also a strong cooperation between
distant institutions, such as those in the State of Pará, with collaborations with Federal
University of Pará (UFPA), Evandro Chagas Institute, State Secretariat of Public Health and
Emilio Goeldi Museum, which shows a common interest of these ICTs toward medicinal
preparations containing plant extracts. In a recent study, Gomes Costa et al. (2018) highlight
the positive side of partnerships between Northeastern and Southeastern institutions to
foster the development of biotechnology in that region, as they observed, through SNA, a
strong interaction between UNICAMP and UFRGSwith organizations in the Northeast.
Other holders stand out in patent number, but do not invest in technological development
in cooperation with other institutions (Figure 6). These are UFPR (13 patents), UFMA (11),
Federal University of Santa Maria (UFSM; seven), Chemyunion Química Ltda. (eight),
Federal University of Goiás (UFG, six), Solábia Biotecnologia (ﬁve), Douglas Guimarães
Figure 5.
Ego network of the
collaboration among
the largest assignees
in quantity of patents
for the sector of
medicinal
preparations
containing products
of plant origin and
that had Brazil as a
priority country
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Cucio (inventor with nine patents), UFPI (Federal University of Piauí; four patents) and UEL
(Londrina State University; two). These demonstrate that non-participation in collaborative
projects that result in technological development is widespread in the country, and not
concentrated in regions where research incentives are scarce; and it is an attitude found in
both public and private sectors.
5. Conclusion and future perspectives
This study analyzed collaboration networks between institutions that produced patents in a
speciﬁc sector of biotechnology, and had Brazil as the priority country. Technologies protected
by patents regardingmedicinal preparations containing plant materials have a high worldwide
interest. With more than 200,000 inventions around the world, Brazil has only 466 patent
families as the priority country, that is, inventions that were ﬁrst ﬁled in Brazil, at INPI
(National Institute of Industrial Property). The study highlights the importance of cooperative
relationships and the advantage of using SNA to better view these ties between actors.
Universities and FAPs are the key drivers of innovation in Brazil, whose actions are seen
through the higher number of patent ﬁlings and the interactions they establish. However, national
participation in innovation in biotechnology is still low, although investments have been a priority
of the national policy for science, technology and innovation for more than a decade and the
country’s basic science is signiﬁcant in this area. We conclude that basic science and technology
development in biotechnology still lack knowledge transfer that corresponds to the effortsmade.
The study has important empirical implications, mainly regarding the urgent need to
establish partnerships to create technological solutions that are relevant not only locally, but
also for the international market, through decisions that foster the participation of foreign
companies in projects developed in Brazil. In addition, we noticed that applied knowledge for
the creation of new technologies comes mainly from public universities. Hence, universities
must spread this knowledge back to industry, through improved education and qualiﬁcation of
human capital concerned with technology transfer activities (Fischer et al., 2018). In addition,
Figure 6.
Components of the
general (bipartite)
network showing
assignees with a
reasonable number of
patents, but who do
not establish
partnerships with
other institutions in
this sector
Brazil as the
priority
country
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there are institutions that develop technology separately, but still have a high capacity of
innovation, proved by the number of patent requests. These institutions could better use their
skills by establishing cooperation with other organizations to promote their innovative efforts
and drive new discoveries in the area.
One limitation regards the restricted ﬁeld that we chose to examine. Although
biotechnology related to herbal medicine has an extensive knowledge and technical capacity,
the study addressed only part of what the country produces in this sector. Therefore, it is
necessary to extend the study to other sectors. In addition, future research should include the
analysis of the collaborations of Brazilian institutions with the global market, and investigate
if the technologies protected primarily in the country attract the interest of international
institutions. Another study proposal that emerges from our results is to check which of the
Brazilian institutions that we studied take part in the routes of technology trends.
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